Attention:
|
David Burton
Kate Tillan
Laura S. Crotty
Dorrie Yale
|
Re:
|
Nanobiotix S.A.
|
||
|
Registration Statement on Form F-1 (File No. 333-250707)
|
(i)
|
Dates of distribution: December 7, 2020 through the date hereof
|
(ii)
|
Number of prospective underwriters to which the preliminary prospectus was furnished: 5
|
(iii)
|
Number of prospectuses furnished to investors: approximately: 822
|
(iv)
|
Number of prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: none
|
By:
|
Jefferies LLC
|
By:
|
/s/ Matthew Kim |
|
Name: Matthew Kim
|
Title: Managing Director
|
By:
|
Evercore Group, .L.L.C.
|
By:
|
/s/ Francois Maisonrouge |
Name: Francois Maisonrouge
|
|
Title: Senior Managing Director
|
By:
|
UBS Securities LLC
|
By:
|
/s/ Arun Master |
Name: Arun Master
|
|
Title: Managing Director
|
By:
|
UBS Securities LLC
|
By:
|
/s/ Christian Parrish |
Name: Christian Parrish
|
|
Title: Director
|
By:
|
Jefferies International LTD
|
By:
|
/s/ Gil Bar-Nahum |
Name: Gil Bar-Nahum
|
|
Title: Managing Director
|
By:
|
Gilbert Dupont SNC
|
By:
|
/s/ Pascal MATHIEU |
Name: Pascal MATHIEU
|
|
Title: CEO
|